London Daily

Focus on the big picture.
Tuesday, Jun 02, 2026

UK approves another antibody treatment for Covid

UK approves another antibody treatment for Covid

The UK has approved another antibody treatment for people with Covid that cuts the risk of severe illness.

It's called sotrovimab, and scientists say preliminary checks suggest it should work well even against new variants such as Omicron.

The drug, given in a drip into a vein, binds to the virus to stop it entering our cells.

In a clinical trial, a single dose reduced the risk of hospitalisation and death by 79% in high risk adults.

It is the second drug of its kind - a monoclonal antibody treatment - that UK regulators have approved.

Both sotrovimab and the other approved antibody treatment, ronapreve, are most effective when taken during the early stages of infection. The Medicines and Healthcare products Regulatory Agency (MHRA) recommends they are used within five days of someone getting symptoms.

Dr June Raine, MHRA chief executive, said: "This is yet another therapeutic that has been shown to be effective at protecting those most vulnerable to Covid-19, and signals another significant step forward in our fight against this devastating disease."

Drug company GSK, which made sotrovimab (Xevudy), says it has run some early tests in the lab to see how well the treatment fares against the new, heavily mutated Covid variant Omicron that is now spreading around the world.

More checks are needed, but researchers say the drug targets a part of the spike protein of the virus that has not yet undergone big changes or mutations, meaning it should work well.

Henny Braund, chief executive of cancer charity Anthony Nolan, said: "This is positive news for blood cancer patients, who we know are less likely to be protected from Covid-19 vaccines than the wider population. It is particularly important that patients can access this treatment immediately, if they contract the virus, and there is clear guidance for doctors on making it available."

What treatments do we have against Covid?


Aside from vaccines that are designed to help prevent infections happening in the first place, as well as cut the risk of getting very ill, there are a few different types of treatments for Covid.

They fall into three main categories:

* Antibodies that can target the virus, taken from either survivors' blood plasma or made in a lab (such as sotrovimab and ronapreve)

* Antiviral pills, such as molnupiravir, that directly affect the coronavirus's ability to thrive inside the body

* Drugs, such as dexamethasone, that calm the immune system

Most people who have Covid do not need any treatment and will recover within a few weeks. You may be able to look after yourself at home. Some of the same things you do to feel better if you have the flu - resting, drinking enough fluids and taking paracetamol or ibuprofen - can help.

If you become more unwell then you should seek medical help.

People who think they may have Covid should get a test and self-isolate to help stop the virus spreading.

Newsletter

Related Articles

0:00
0:00
Close
Japanese Technology Firm Fujitsu Launches Advanced Artificial Intelligence Tool for Corporate Disclosures
South Africa Officially Launches Nationwide Campaign for Highly Contested Local Government Elections
United Kingdom Commits Additional Funding for Unexploded Ordnance Clearance in Laos
Singapore Announces Stringent New Greenhouse Gas Regulations for Commercial Cooling Systems
Cambodia and Thailand Hold High-Level Border Security Talks at United Nations Headquarters
Myanmar Military Government and China Sign Major Agreement to Upgrade Media and Cultural Cooperation
Knife Attack at Swiss Train Station Leaves Three Injured in Suspected Act of Domestic Terrorism
Transnational Extortion Gang Threatens Canadian Police With Army of One Thousand Armed Operatives
Australia Imposes Forty-Two-Day Quarantine on Cruise Ship Passengers Following Deadly Hantavirus Outbreak
International Monetary Fund Unlocks Seven Hundred Million United States Dollars for Sri Lanka Following Economic Reforms
Australia Launches Record One Point Four Billion Dollar Lawsuit Against Chemical Giant 3M Over Contamination
China and Canada Foreign Ministers Meet in Ottawa in Effort to Stabilize Strained Diplomatic Ties
Indonesia Demands Urgent United Nations Security Council Reform Amid Escalating Global Conflicts
Extreme Weather Patterns Trigger Severe Drought in Madagascar and Destructive Flooding in East Africa
Indian State of Karnataka Faces Political Upheaval as Chief Minister Siddaramaiah Abruptly Resigns
Philippines and Japan Reaffirm Defense Ties as Crucial for Indo-Pacific Regional Stability
Norway Joins French Nuclear Deterrence Initiative in Major Shift for European Security Architecture
Global Critical Mineral Alliances Expand as Western Nations Move to Counter Chinese Supply Dominance
United States Imposes Fifty Percent Tariffs on Mexican Steel and Aluminum Ahead of Trade Pact Review
European Union and China Head Toward Major Trade Conflict Over Clean Technology Exports
United States Economic Growth Severely Downgraded to One Point Six Percent as Stagflation Fears Mount
World Health Organization Warns Central African Ebola Epidemic is Outpacing Containment Efforts
United States Treasury Department Conditions Sanctions Relief on Reopening of the Strait of Hormuz
Iranian Air Defenses Intercept and Destroy United States Military Drone Over Bushehr Province
Iranian Armed Forces Launch Ballistic Missiles Toward Unspecified Targets Prompting Regional Condemnation
United Nations Secretary-General Warns Global Order Facing Highest Level of Conflict Since 1945
Israel Issues Sweeping Evacuation Orders in Southern Lebanon Amid Intensified Hezbollah Conflict
Russia Announces Systemic Military Strikes Targeting Ukrainian Defense and Energy Infrastructure
United States and Iranian Negotiators Reach Draft Agreement to Extend Ceasefire and Resume Nuclear Talks
United Nations Security Council Deeply Divided Over United States Capture of Venezuelan President
US and Iran Exchange Direct Military Strikes Amid Fragile Gulf Ceasefire
World Health Organization Warns of Catastrophic Ebola Outbreak in DR Congo
Russia Threatens New Wave of Strikes on Ukrainian Infrastructure and Embassies
Scientists Warn Atlantic Ocean Currents Could Collapse Faster Than Projected
Anthropic Reaches $900 Billion Valuation in Historic AI Funding Round
Washington Imposes Crippling Sanctions on Iranian Maritime Authority
Japan and the Philippines Initiate Strategic Intelligence-Sharing Pact
Microsoft Deploys Autonomous Computer-Using AI Agents to Global Markets
Anthropic Secures $45 Billion Compute Infrastructure Agreement With SpaceX
U.S. Director of National Intelligence Resigns Amid Administration Shakeup
Micron Technology Crosses Trillion-Dollar Valuation Amid Unprecedented Hardware Demand
Canada and Germany Finalize Historic Long-Term LNG Export Agreement
China Expands International Travel Restrictions on Domestic AI Researchers
Japan Approves Sweeping Overhaul of National Intelligence Apparatus
Global Airlines Scramble Logistics as Middle East Airspace Remains Fractured
Japan's Naphtha Imports Plunge 47 Percent Amid Strait of Hormuz Closure
Global Crude Prices Retreat Below $96 as Gulf Tensions Momentarily Ease
Generative AI Outperforms Human Baselines in Landmark Global Creativity Study
NASA Partners With Private Aerospace to Unveil Permanent Lunar Base Architecture
South Korean Equity Markets Surge on Next-Generation Memory Chip Frenzy
×